Pfizer raises 2026 guidance after Q3, reports pipeline progress and new CFONov 3Quarterly updateBioNTech SEC4 Therapeutics, Inc.
Lilly advances obesity and inflammation pipeline with new Phase 1 trials, Phase 2 updatesOct 9Weekly roundup, 10 itemsEli Lillyeloralintide
GSK registers three new Phase 3 trials spanning asthma, prostate cancer, ovarian cancerOct 2Weekly roundup, 11 itemscabotegravirganfeboroleUpdated
Lilly registers three new early trials: olomorasib in colorectal cancer, two obesity studiesSep 11Weekly roundup, 3 itemsEli Lillyeloralintide
Vertex registers Phase 1 drug interaction study for VX-407 with oral contraceptivesAug 28Trial updateVertex Pharmaceuticals Inc / Ma
Viatris raises 2026 guidance, reports FDA approvals and Tyrvaya sale in Q2 updateAug 6Quarterly updatevareniclineViatris Inc.